Pain mechanisms in patients with chronic pain

Clinical Drug Investigation

Volumn 32, Issue SUPPL. 1, 2012, Pages 45-52

  Fornasari, Diego ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DIHYDROCODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; MORPHINE; NEUROTRANSMITTER; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; TRAMADOL; NARCOTIC ANALGESIC AGENT;

AUTONOMIC NEUROPATHY; CARDIOVASCULAR SYMPTOM; CHRONIC PAIN; CONSTIPATION; DIGESTIVE SYSTEM INJURY; DRUG DEPENDENCE; HUMAN; NAUSEA; NERVE FIBER; NEUROBIOLOGY; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; PAIN; PAIN THRESHOLD; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SENSORY NERVE; VOMITING; METABOLISM; SENSORY NERVE CELL; TIME; TREATMENT OUTCOME;

ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC PAIN; HUMANS; NEOPLASMS; NERVOUS SYSTEM DISEASES; NEURALGIA; PAIN MANAGEMENT; PAIN MEASUREMENT; NERVE FIBERS; SENSORY RECEPTOR CELLS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857522282     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11630070-000000000-00000     Document Type: Review

References (31)

1. Melzack R, Wall PD. Pain mechanisms: A new theory. Science 1965;150(3699):971-9
2. Walsh NE, Dumitru D, Schoenfeld LS, et al. Treatment of the Patient with Chronic Pain. In: De Lisa JA, Gans BM, Walsh NE, Bockenek WL, Frontera WR, Geringer SR, et al., editors. Physical Medicine & Rehabilitation: Principles and Practice. Philadelphia: Lippincott Williams & Wilkins; 2005:497-8
3. Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140(6):441-51 (Pubitemid 38327332)
4. Malik B, Stillman M. Pain Syndromes. In: Savitz S, Ronthal M, editors. Neurology Review for Psychiatrists. 1st Edition ed. Philadelphia: Lippincott Williams & Wilkins; 2009:253-5
5. Koltzenburg M, Scadding J. Neuropathic pain. Curr Opin Neurol 2001;14(5):641-7 (Pubitemid 32964585)
6. Improvement. IfCS. Health care guideline: Assessment and management of acute pain. 2008 [updated 2008; cited 13 September 2011]; Available from: http://www.icsi.org/pain-acute/pain-acute-assessment-and-management-of-3.html
7. Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br J Anaesth 2001;87(1):3-11 (Pubitemid 32631671)
8. Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63(1):17-32 (Pubitemid 36132511)
9. Schaible HG, Richter F. Pathophysiology of pain. Langenbecks Arch Surg 2004;389(4):237-43 (Pubitemid 39128533)
10. Stucky CL, Gold MS, Zhang X. Mechanisms of pain. Proc Natl Acad Sci U S A 2001;98(21):11845-6 (Pubitemid 32959788)
11. Dickenson AH. The roles of transmitters and their receptors in systems related to pain and analgesia. In: Max M, editor. Pain. Seattle: International Association for the Study of Pain Press, 1999:381
12. Heller PH, Green PG, Tanner KD, et al. Peripheral Neural Contributions to Inflammation. In: Fields HL, Liebeskind JC, editors. Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Seattle: International Association for the Study of Pain Press, 1994:31-3
13. Wilcox GL. Pharmacology of pain and analgesia. In: Max M, editor. Pain, an updated review. Seattle: International Association for the Study of Pain, 1999;573
14. Wood S. Anatomy and physiology of pain. 2008 [updated 2008; cited 15 September 2011]; Available from: http://www.nursingtimes.net/nursing-practice/ 1860931.article
15. Farquhar-Smith W. Anatomy, physiology and pharmacology of pain. Anaesth Intensive Care Med 2008;9(1):3-7
16. Ko S, Zhuo M. Central plasticity and persistent pain. Drug Discovery Today Dis Mod 2004;1:101-6 (Pubitemid 41123758)
17. Curatolo M, Arendt-Nielsen L, Petersen-Felix S. Central hypersensitivity in chronic pain: mechanisms and clinical implications. Phys Med Rehabil Clin N Am 2006;17(2):287-302
18. Rang HP, Bevan S, Dray A. Chemical activation of nociceptive peripheral neurones. Br Med Bull 1991;47(3):534-48
19. Siddall PJ, Cousins MJ. Spinal pain mechanisms. Spine (Phila Pa 1976) 1997;22(1):98-104
20. Ong CK, Lirk P, Tan CH, et al. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res 2007;5(1):19-34 (Pubitemid 350218777)
21. Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005;64(5):669-81 (Pubitemid 40559291)
22. Scott PA, Kingsley GH, Smith CM, et al. Non-steroidal antiinflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis 2007;66(10):1296-304 (Pubitemid 47492471)
23. Trescot AM, Datta S, Lee M, et al. Opioid pharmacology. Pain Physician 2008;11(2 Suppl.):S133-53 (Pubitemid 351682083)
24. Savage SR, Horvath R. Opioid Therapy of Pain. In: Ries RK, Fiellin DA, Miller SC, Saitz R, editors. Principles of Addiction Medication. Philadelphia: Lippincott Williams & Wilkins, 2009:1330-2
25. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001;19(9):2542-54 (Pubitemid 32391226)
26. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med 2007;167(16):1752-9 (Pubitemid 47403063)
27. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279(15):1200-5 (Pubitemid 28193431)
28. Lee C, Morton CC. Structural genomic variation and personalized medicine. N Engl J Med 2008;358(7):740-1 (Pubitemid 351240757)
29. Eckhardt K, Li S, Ammon S, et al. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation. Pain 1998;76(1-2):27-33 (Pubitemid 28304939)
30. Mikus G, Weiss J. Influence of CYP2D6 genetics on opioid kinetics, metabolism and response. Curr Pharmacogenom 2005;3(1):43-52 (Pubitemid 40352698)
31. Stamer UM, Musshoff F, Kobilay M, et al. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Clin Pharmacol Ther 2007;82(1):41-7 (Pubitemid 46944194)